What to Expect in U.S. Healthcare in 2026 and Beyond
McKinsey forecasts that healthcare EBITDA as a percentage of national health expenditures could decline from 8.9% in 2024 to 8.7% by 2027 as cost pressure intensifies. Health-services tech, specialty pharmacy, and ambulatory care are projected to grow despite the broader margin compression. The report offers a data-rich view of where the sector is headed and which segments will outperform.
Operators allocating capital or building growth plans need to understand the macro trajectory — particularly the divergence between declining average margins and strong segment-specific growth.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.